"Gently rough": The vaccine potential of a Salmonella enterica regulatory lipopolysaccharide mutant

Journal of Infectious Diseases

Volumn 198, Issue 11, 2008, Pages 1699-1706

  Nagy, Gábor ^a   Palkovics, Tamás ^a   Otto, Andreas ^b   Kusch, Harald ^b   Kocsis, Béla ^a   Dobrindt, Ulrich ^c   Engelmann, Susanne ^b   Hecker, Michael ^b   Emody, Levente ^a   Pál, Tibor ^a   Hacker, Jörg ^c  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; EPITOPE; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LIVE VACCINE; MEMBRANE PROTEIN; PORIN; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DOWN REGULATION; ENTEROBACTERIACEAE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IMMUNOBLOTTING; IMMUNOGENICITY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; TYPHOID FEVER; VACCINATION;

ANIMALS; FEMALE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SALMONELLA VACCINES; SPECIES SPECIFICITY;

EID: 56649092936     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/593069     Document Type: Article

References (50)

1. Girard MP, Steele D, Chaignat CL, Kieny MP. A review of vaccine research and development: human enteric infections. Vaccine 2006; 24:2732-50.
2. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 2006; 34:S20-8.
3. Nagy G, Pal T. Lipopolysaccharide: a tool and target in enterobacterial vaccine development. Biol Chem 2008; 389:513-20.
4. Bailey MJ, Hughes C, Koronakis V. RfaH and the ops element, components of a novel system controlling bacterial transcription elongation. Mol Microbiol 1997; 26:845-51.
5. Lindberg AA, Hellerqvist CG. Rough mutants of Salmonella typhimurium: immunochemical and structural analysis of lipopolysaccharides from rfaH mutants. J Gen Microbiol 1980; 116:25-32.
6. Creeger ES, Schulte T, Rothfield LI. Regulation of membrane glycosyltransferases by the sfrB and rfaH genes of Escherichia coli and Salmonella typhimurium. J Biol Chem 1984; 259:3064-9.
7. Wang L, Jensen S, Hallman R, Reeves PR. Expression of the O antigen gene cluster is regulated by RfaH through the JUMPstart sequence. FEMS Microbiol Lett 1998; 165:201-6.
8. Nagy G, Dobrindt U, Schneider G, Khan AS, Hacker J, Emody L. Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli. Infect Immun 2002; 70:4406-13.
9. Nagy G, Danino V, Dobrindt U, et al. Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate. Infect Immun 2006; 74:5914-25.
10. Gerlach RG, Jackel D, Stecher B, et al. Salmonella pathogenicity island 4 encodes a giant non-fimbrial adhesin and the cognate type 1 secretion system. Cell Microbiol 2007; 9:1834-50.
11. Kiss T, Morgan E, Nagy G. Contribution of SPI-4 genes to the virulence of Salmonella enterica. FEMS Microbiol Lett 2007; 275:153-9.
12. Nagy G, Dobrindt U, Hacker J, Emody L. Oral immunization with an rfaH mutant elicits protection against salmonellosis in mice. Infect Immun 2004; 72:4297-301.
13. Wei J, Goldberg MB, Burland V, et al. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun 2003; 71:2775-86.
14. Oelschlaeger TA, Tall BD. Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract. Infect Immun 1997; 65:2950-8.
15. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97:6640-5.
16. Osborn MJ, Munson R. Separation of the inner (cytoplasmic) and outer membranes of gram-negative bacteria. Methods Enzymol 1974; 31:642-53.
17. Mulford CA, Osborn MJ. An intermediate step in translocation of lipopolysaccharide to the outer membrane of Salmonella typhimurium. Proc Natl Acad Sci USA 1983; 80:1159-63.
18. Yethon JA, Vinogradov E, Perry MB, Whitfield C. Mutation of the lipopolysaccharide core glycosyltransferase encoded by waaG destabilizes the outer membrane of Escherichia coli by interfering with core phosphorylation. J Bacteriol 2000; 182:5620-3.
19. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981; 291:238-9.
20. Russo TA, Beanan JM, Olson R, et al. A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate. Vaccine 2007; 25:3859-70.
21. Dietrich G, Griot-Wenk M, Metcalfe IC, Lang AB, Viret JF. Experience with registered mucosal vaccines. Vaccine 2003; 21:678-83.
22. Raupach B, Kaufmann SH. Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain? Microbes Infect 2001; 3:1261-9.
23. Guzman CA, Borsutzky S, Griot-Wenk M, et al. Vaccines against typhoid fever. Vaccine 2006; 24:3804-11.
24. Toguchi A, Siano M, Burkart M, Harshey RM. Genetics of swarming motility in Salmonella enterica serovar typhimurium: critical role for lipopolysaccharide. J Bacteriol 2000; 182:6308-21.
25. Nevola JJ, Laux DC, Cohen PS. In vivo colonization of the mouse large intestine and in vitro penetration of intestinal mucus by an avirulent smooth strain of Salmonella typhimurium and its lipopolysaccharidedeficient mutant. Infect Immun 1987; 55:2884-90.
26. Shaio MF, Rowland H. Bactericidal and opsonizing effects of normal serum on mutant strains of Salmonella typhimurium. Infect Immun 1985; 49:647-53.
27. Hoare A, Bittner M, Carter J, et al. The outer core lipopolysaccharide of Salmonella enterica serovar Typhi is required for bacterial entry into epithelial cells. Infect Immun 2006; 74:1555-64.
28. Curtiss R III, Zhang X, Wanda SY, et al. Induction of host immune responses using Salmonella-vectored vaccines. In: Brogden KA, Minion FC, Cornick N, et al, eds. Virulence mechanisms of bacterial pathogens. 4th ed. Washington, DC: American Society for Microbiology Press, 2007:297-313.
29. Spier RE. On the need for, and the delivery of, cross-protective vaccines. Vaccine 2005; 23:2027-9.
30. Heithoff DM, Enioutina EY, Daynes RA, Sinsheimer RL, Low DA, Mahan MJ. Salmonella DNA adenine methylase mutants confer crossprotective immunity. Infect Immun 2001; 69:6725-30.
31. Mohler VL, Heithoff DM, Mahan MJ, et al. Cross-protective immunity conferred by a DNA adenine methylase deficient Salmonella enterica serovar Typhimurium vaccine in calves challenged with Salmonella serovar Newport. Vaccine 2008; 26:1751-8.
32. Mohler VL, Heithoff DM, Mahan MJ, et al. Cross-protective immunity in calves conferred by a DNA adenine methylase deficient Salmonella enterica serovar Typhimurium vaccine. Vaccine 2006; 24:1339-45.
33. Sebkova A, Karasova D, Crhanova M, Budinska E, Rychlik I. aro mutations in Salmonella enterica cause defects in cell wall and outer membrane integrity. J Bacteriol 2008; 190:3155-60.
34. Hofstra H, Van Tol JD, Dankert J. Cross-reactivity of major outer membrane proteins of Enterobacteriaceae, studied by crossed immunoelectrophoresis. J Bacteriol 1980; 143:328-37.
35. Isibasi A, Ortiz V, Vargas M, et al. Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d,Vi. Infect Immun 1988; 56:2953-9.
36. Tabaraie B, Sharma BK, Sharma PR, Sehgal R, Ganguly NK. Evaluation of Salmonella porins as a broad spectrum vaccine candidate. Microbiol Immunol 1994; 38:553-9.
37. Kuusi N, Nurminen M, Saxen H, Valtonen M, Makela PH. Immunization with major outer membrane proteins in experimental salmonellosis of mice. Infect Immun 1979; 25:857-62.
38. Udhayakumar V, Muthukkaruppan VR. Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice. Infect Immun 1987; 55:816-21.
39. van Alphen W, Lugtenberg B, Berendsen W. Heptose-deficient mutants of Escherichia coli K12 deficient in up to three major outer membrane proteins. Mol Gen Genet 1976; 147:263-9.
40. Ried G, Hindennach I, Henning U. Role of lipopolysaccharide in assembly of Escherichia coli outer membrane proteins OmpA, OmpC, and OmpF. J Bacteriol 1990; 172:6048-53.
41. Rivera M, Bertasso A, McCaffrey C, Georgopapadakou NH. Porins and lipopolysaccharide of Escherichia coli ATCC 25922 and isogenic rough mutants. FEMS Microbiol Lett 1993; 108:183-7.
42. Sha J, Fadl AA, Klimpel GR, Niesel DW, Popov VL, Chopra AK. The two murein lipoproteins of Salmonella enterica serovar Typhimurium contribute to the virulence of the organism. Infect Immun 2004; 72:3987-4003.
43. Sha J, Agar SL, Baze WB, et al. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. Infect Immun 2008; 76:1390-409.
44. Braun V, Bosch V, Klumpp ER, Neff I, Mayer H, Schlecht S. Antigenic determinants of murein lipoprotein and its exposure at the surface of Enterobacteriaceae. Eur J Biochem 1976; 62:555-66.
45. Henriksen AZ, Maeland JA, Brakstad OG. Monoclonal antibodies against three different enterobacterial outer membrane proteins: characterization, cross-reactivity, and binding to bacteria. APMIS 1989; 97:559-68.
46. Miller VL, Falkow S. Evidence for two genetic loci in Yersinia enterocolitica that can promote invasion of epithelial cells. Infect Immun 1988; 56:1242-8.
47. Bliska JB, Falkow S. Bacterial resistance to complement killing mediated by the Ail protein of Yersinia enterocolitica. Proc Natl Acad Sci USA 1992; 89:3561-5.
48. Vogt J, Schulz GE. The structure of the outer membrane protein OmpX from Escherichia coli reveals possible mechanisms of virulence. Structure 1999; 7:1301-9.
49. Maisnier-Patin K, Malissard M, Jeannin P, et al. The outer membrane protein X from Escherichia coli exhibits immune properties. Vaccine 2003; 21:3765-74.
50. Mildiner-Earley S, Miller VL. Characterization of a novel porin involved in systemic Yersinia enterocolitica infection. Infect Immun 2006; 74:4361-5.